Theravance Biopharma (TBPH) Enterprise Value Growth (5y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Theravance Biopharma | 823.54 Mn | 428.87 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -13.45% |
| Dec 31, 2025 | 10.29% |
| Sep 30, 2025 | 13.14% |
| Jun 30, 2025 | 5.02% |
| Mar 31, 2025 | 23.11% |
| Dec 31, 2024 | 20.65% |
| Sep 30, 2024 | 3.63% |
| Jun 30, 2024 | 24.67% |
| Mar 31, 2024 | 25.45% |
| Dec 31, 2023 | 27.33% |
| Sep 30, 2023 | 14.91% |
| Jun 30, 2023 | 13.85% |
| Mar 31, 2023 | 10.43% |
| Dec 31, 2022 | 1.24% |
| Sep 30, 2022 | -7.76% |
| Jun 30, 2022 | 18.16% |
| Mar 31, 2022 | 17.79% |
| Dec 31, 2021 | 19.12% |
| Sep 30, 2021 | 1.27% |
| Jun 30, 2021 | -1.19% |
| Mar 31, 2021 | -3.14% |
| Dec 31, 2020 | -11.18% |
| Sep 30, 2020 | -12.83% |
| Jun 30, 2020 | -15.75% |
| Mar 31, 2020 | -15.57% |
| Dec 31, 2019 | -1.98% |
| Sep 30, 2019 | 17.34% |
| Jun 30, 2019 | -2.55% |